Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress
Main Content

Teaching Course 4305

Genetic Testing for Movement Disorders in Clinical Practice

Wednesday, October 8, 2025
14:00 - 15:30 | Room TBD

In this session, the faculty will discuss how to interpret a genetic test, how to perform genetic counseling and the role of genetic testing in at-risk populations.


Chairs:

Niccolo Mencacci, USA
Kathryn Peall, United Kingdom

Presenters:

How to Interpret a Genetic Test Result
Enza Maria Valente, Italy

Genetic Counseling: Before and After Testing
Gerard Saranza, Philippines

Genetic Testing in Populations At-Risk
Mario Cornejo-Olivas, Peru

CSPC Liaisons:

Pramod Pal, India
Francesca Morgante, United Kingdom

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Evaluate the content of genetic test reports and the implications of a positive, negative or inconclusive test results in patients with Movement Disorders
  2. Plan pre- and post-test genetic counseling in patients with Movement Disorders
  3. Describe the role of genetic testing in at-risk populations including Parkinson’s and Huntington’s disease

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level

Beginner / Foundational
Intermediate / Experienced

Focus

Clinical
Translational